Literature DB >> 33983571

Translational Research in Surgical Oncology: Introduction and My Own Experience as a Surgeon-Scientist.

Dong-Young Noh1,2.   

Abstract

Translational research is possible when scientists have broad knowledge of not only basic research, but also clinical science, which is acquired via experience in patient care. These requirements cannot always be met by one individual, and, hence, collaboration between suitably qualified individuals is the key for the progress of translational research. However, it is vital that translational research is conducted by an investigator who has knowledge about all fields. I could be a good conductor in that sense, because as an oncology surgeon, I have considerable experience in working with patients; in addition, I have a background in biochemistry and have started my basic research laboratory. Thus, I can use these qualifications to my advantage to build a tissue bank as the first step, and initiate small-scale experiments such as estimating the DNA or protein levels in specific tissues or blood samples. Once I successfully launch good research products and publish in peer-reviewed journals, I intend to build a large research group focusing on large-scale studies on single nucleotide polymorphisms and proteomics. These translational approaches can overcome several unsolved clinical problems. Many of my research products, for example, patents and new techniques such as Mastocheck@, are designed for improving the clinical outcomes in patients.

Entities:  

Keywords:  Bioinformatics; Breast cancer; Genomics; Proteomics; Surgical oncology; Translational research

Mesh:

Substances:

Year:  2021        PMID: 33983571     DOI: 10.1007/978-981-32-9620-6_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  1 in total

1.  The CD49d+/high subpopulation from isolated human breast sarcoma spheres possesses tumor-initiating ability.

Authors:  Kyung-Min Lee; Wonshik Han; Jong Bin Kim; Incheol Shin; Eunyoung Ko; In Ae Park; Dong Sup Lee; Kuenhee Oh; Dong-Young Noh
Journal:  Int J Oncol       Date:  2011-12-08       Impact factor: 5.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.